Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,959 | 4,088 | 2,331 | 4,646 | 2,727 |
| Depreciation Amortization | 647 | 320 | 173 | 247 | 197 |
| Income taxes - deferred | 441 | 241 | -1 | 429 | 22 |
| Accounts receivable | -1,273 | -63 | -718 | 2,051 | 1,925 |
| Other Working Capital | -1,884 | -202 | -520 | 787 | 1,013 |
| Other Operating Activity | 1,345 | 102 | 723 | -2,031 | -1,910 |
| Operating Cash Flow | $6,236 | $4,485 | $1,988 | $6,129 | $3,974 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -13,379 | -8,631 | -2,146 | -5,201 | -828 |
| PPE Investments | N/A | N/A | N/A | 1 | 1 |
| Investing Cash Flow | $-13,379 | $-8,631 | $-2,146 | $-5,200 | $-827 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,814 | 1,673 | 37 | 2,147 | 205 |
| Common Stock Repurchased | -1,182 | -701 | -114 | -830 | -751 |
| Other Financing Activity | 3,189 | 1,910 | 1,158 | 1,940 | 1,485 |
| Financing Cash Flow | $4,821 | $2,882 | $1,081 | $3,257 | $939 |
| Beginning Cash Position | 9,811 | 9,811 | 9,811 | 5,625 | 5,625 |
| End Cash Position | 7,488 | 8,547 | 10,734 | 9,811 | 9,711 |
| Net Cash Flow | $-2,323 | $-1,264 | $923 | $4,186 | $4,087 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,236 | 4,485 | 1,988 | 6,129 | 3,974 |
| Free Cash Flow | 6,236 | 4,485 | 1,988 | 6,129 | 3,974 |